Cargando…

New Immunometabolic Strategy Based on Cell Type-Specific Metabolic Reprogramming in the Tumor Immune Microenvironment

Immunometabolism is an emerging discipline in cancer immunotherapy. Tumor tissues are heterogeneous and influenced by metabolic reprogramming of the tumor immune microenvironment (TIME). In the TIME, multiple cell types interact, and the tumor and immune cells compete for limited nutrients, resultin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sung, Ji-Yong, Cheong, Jae-Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909366/ https://www.ncbi.nlm.nih.gov/pubmed/35269390 http://dx.doi.org/10.3390/cells11050768

Ejemplares similares

Metabolic reprogramming by miRNAs in the tumor microenvironment: Focused on immunometabolism
por: Alshahrani, Shadia Hamoud, et al.
Publicado: (2022)

Nanoparticle-Mediated Lipid Metabolic Reprogramming of T Cells in Tumor Microenvironments for Immunometabolic Therapy
por: Kim, Dongyoon, et al.
Publicado: (2021)

Tumor Microenvironment-Induced Immunometabolic Reprogramming of Natural Killer Cells
por: Chambers, Andrea M., et al.
Publicado: (2018)

Metabolic Reprogramming of Immune Cells at the Maternal-Fetal Interface and the Development of Techniques for Immunometabolism
por: Wei, Yiqiu, et al.
Publicado: (2021)

Metabolic Reprogramming in the Tumor Microenvironment With Immunocytes and Immune Checkpoints
por: Xu, Yaolin, et al.
Publicado: (2021)

Intercellular communications and metabolic reprogramming as new predictive markers for immunotherapy responses in gastric cancer
por: Sung, Ji‐Yong, et al.
Publicado: (2022)

Immunometabolic reprogramming, another cancer hallmark
por: Kumar, Vijay, et al.
Publicado: (2023)

Interplay of Immunometabolism and Epithelial–Mesenchymal Transition in the Tumor Microenvironment
por: Chou, Ming-Yu, et al.
Publicado: (2021)

Immunometabolism in the tumor microenvironment and its related research progress
por: Zhang, Ziheng, et al.
Publicado: (2022)

The Matrisome Is Associated with Metabolic Reprograming in Stem-like Phenotypes of Gastric Cancer
por: Sung, Ji-Yong, et al.
Publicado: (2022)

Single Cell Analysis Reveals Reciprocal Tumor-Macrophage Intercellular Communications Related with Metabolic Reprogramming in Stem-like Gastric Cancer
por: Sung, Ji-Yong, et al.
Publicado: (2022)

Effects of PD-1 Signaling on Immunometabolic Reprogramming
por: Boussiotis, Vassiliki A., et al.
Publicado: (2022)

Macrophages and Metabolic Reprograming in the Tumor Microenvironment
por: Liu, Jin, et al.
Publicado: (2022)

Understanding metabolic reprogramming in tumor microenvironment
por: Shu, Shaokun, et al.
Publicado: (2022)

Metabolic reprogramming in tumors: Contributions of the tumor microenvironment
por: Lane, Andrew N., et al.
Publicado: (2019)

Metabolic reprogramming of immune cells: Shaping the tumor microenvironment in hepatocellular carcinoma
por: Xia, Yujia, et al.
Publicado: (2021)

Reprogramming of glutamine metabolism and its impact on immune response in the tumor microenvironment
por: Ma, Guofeng, et al.
Publicado: (2022)

Obesity Is Associated with Immunometabolic Changes in Adipose Tissue That May Drive Treatment Resistance in Breast Cancer: Immune-Metabolic Reprogramming and Novel Therapeutic Strategies
por: Savva, Constantinos, et al.
Publicado: (2023)

Pan-Cancer Analysis Reveals Distinct Metabolic Reprogramming in Different Epithelial–Mesenchymal Transition Activity States
por: Sung, Ji-Yong, et al.
Publicado: (2021)

The role of lipid metabolic reprogramming in tumor microenvironment
por: Yang, Kai, et al.
Publicado: (2023)

Metabolic Reprogramming of HCC: A New Microenvironment for Immune Responses
por: Foglia, Beatrice, et al.
Publicado: (2023)

Role of PKM2-Mediated Immunometabolic Reprogramming on Development of Cytokine Storm
por: Liu, Zhijun, et al.
Publicado: (2021)

Targeting T Cell Immunometabolism for Cancer Immunotherapy; Understanding the Impact of the Tumor Microenvironment
por: Mockler, Mary B., et al.
Publicado: (2014)

Very‐low‐carbohydrate diet enhances human T‐cell immunity through immunometabolic reprogramming
por: Hirschberger, Simon, et al.
Publicado: (2021)

Metabolic Reprogramming Induces Immune Cell Dysfunction in the Tumor Microenvironment of Multiple Myeloma
por: Wu, Shaojie, et al.
Publicado: (2021)

Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment
por: Zhu, Yifei, et al.
Publicado: (2022)

TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy
por: Huang, Lan, et al.
Publicado: (2018)

Reprogramming the tumor microenvironment with biotechnology
por: Kim, Minjeong, et al.
Publicado: (2023)

Metabolic Reprogramming in Tumor-Associated Macrophages in the Ovarian Tumor Microenvironment
por: Kumar, Sudhir, et al.
Publicado: (2022)

Influence of the Tumor Microenvironment on Cancer Cells Metabolic Reprogramming
por: Gouirand, Victoire, et al.
Publicado: (2018)

Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment
por: Sasidharan Nair, Varun, et al.
Publicado: (2021)

The Role of Extracellular Vesicles in Metabolic Reprogramming of the Tumor Microenvironment
por: Fridman, Eran S., et al.
Publicado: (2022)

Metabolic Reprogramming Induces Macrophage Polarization in the Tumor Microenvironment
por: Wang, Shilin, et al.
Publicado: (2022)

Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment
por: Tan, Shiming, et al.
Publicado: (2023)

Metabolic reprogramming of the tumor immune microenvironment in ovarian cancer: A novel orientation for immunotherapy
por: Lin, Yi, et al.
Publicado: (2022)

Partners in crime: The feedback loop between metabolic reprogramming and immune checkpoints in the tumor microenvironment
por: Benito-Lopez, Jesus J., et al.
Publicado: (2023)

Targeting Strategies for Aberrant Lipid Metabolism Reprogramming and the Immune Microenvironment in Esophageal Cancer: A Review
por: Cui, Meng-Ying, et al.
Publicado: (2022)

Indoleamine 2,3-dioxygenase regulates anti-tumor immunity in lung cancer by metabolic reprogramming of immune cells in the tumor microenvironment
por: Schafer, Cara C., et al.
Publicado: (2016)

Metabolic reprogramming of the ovarian cancer microenvironment in the development of antiangiogenic resistance: Metabolic reprogramming of the OC microenvironment
por: Yue, Huiran, et al.
Publicado: (2023)

Noncoding RNAs link metabolic reprogramming to immune microenvironment in cancers
por: Zhang, Yiyin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jhihk6fm46tgj817355d7i4st5